EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil

Overview of attention for article published in Trials, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 13 tweets from 9 users, with an upper bound of 11,283 followers.

RT @CheTranquiloID: Sharing #EVITAdengue, protocol now published in #Trials @BioMedCentral this study evaluates efficacy of @WMPglobal #Wo…

RT @CheTranquiloID: Sharing #EVITAdengue, protocol now published in #Trials @BioMedCentral this study evaluates efficacy of @WMPglobal #Wo…

RT @CheTranquiloID: Sharing #EVITAdengue, protocol now published in #Trials @BioMedCentral this study evaluates efficacy of @WMPglobal #Wo…

Sharing #EVITAdengue, protocol now published in #Trials @BioMedCentral this study evaluates efficacy of @WMPglobal #Wolbachia infected mosquitoes in reducing #dengue infection in Belo Horizonte Brazil. #vectorcontrol #arbovirus #emerginginfections https:

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 9 additional tweets.